Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total Neoadjuvant Therapy in Rectal Cancer
NCT04747951Phase 4Unknown
- Sponsor
- State Scientific Centre of Coloproctology
- Start
- Oct 2020
- Primary completion
- Oct 2023
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oxaliplatin, capecitabine in rectal cancer, sponsored by State Scientific Centre of Coloproctology. Status: unknown.
02
Drugs
oxaliplatincapecitabine
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT04747951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04747951.